Protection from Ischemic Heart Injury by a Vigilant Heme Oxygenase-1 Plasmid System

Hypertension

Volumn 43, Issue 4, 2004, Pages 746-751

  Tang, Yao Liang ^a   Tang, Yi ^b   Zhang, Y Clare ^a   Qian, Keping ^a   Shen, Leping ^a   Phillips, M Ian ^a,c  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ADM 200 ^*  (United States)

Author keywords

Genes; Heart; Ischemia

Indexed keywords

CASPASE 3; GENE PRODUCT; HEME OXYGENASE 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PLASMID VECTOR; PROTEIN BAX; PROTEIN BCL 2; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; DIASTOLE; DRUG MECHANISM; EMBRYO; GENE OVEREXPRESSION; GENE SWITCHING; GENE THERAPY; GENE TRANSFER; GENETIC TRANSFECTION; HEART CATHETER; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CONTRACTILE FORCE; HEART MUSCLE FIBROSIS; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PLASMID; PRIORITY JOURNAL; REPORTER GENE; TRICHOME;

APOPTOSIS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; BCL-2-ASSOCIATED X PROTEIN; BINDING SITES; BIOSENSING TECHNIQUES; CASPASE 3; CASPASES; CELL HYPOXIA; ENDOMYOCARDIAL FIBROSIS; GENE EXPRESSION REGULATION; GENE THERAPY; GENES, SYNTHETIC; GENETIC VECTORS; HEME OXYGENASE (DECYCLIZING); HEME OXYGENASE-1; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MEMBRANE PROTEINS; MYOCARDIAL INFARCTION; MYOSIN LIGHT CHAINS; PLASMIDS; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; REGULATORY SEQUENCES, NUCLEIC ACID; SACCHAROMYCES CEREVISIAE PROTEINS; TATA BOX; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS;

EID: 1642501642     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000120152.27263.87     Document Type: Article

References (22)

1. Melo LG, Agrawal R, Zhang L, Rezvani M, Mangi AA, Ehsan A, Griese DP, Dell'Acqua G, Mann MJ, Oyama J, Yet SF, Layne MD, Perrella MA, Dzau VJ. Gene therapy strategy for long-term myocardial protection using adeno-associated virus-mediated delivery of heme oxygenase gene. Circulation. 2002;105:602-607.
2. Platt JL, Nath KA. Heme oxygenase: protective gene or Trojan horse. Nat Med. 1998;4:1364-1365.
3. Phillips MI, Tang Y, Schmidt-Ott K, Qian K, Kagiyama S. Vigilant vector: heart-specific promoter in an adeno-associated virus vector for cardioprotection. Hypertension. 2002;39:651-655.
4. Tang Y, Jackson M, Qian K, Phillips MI. Hypoxia inducible double plasmid system for myocardial ischemia gene therapy. Hypertension. 2002;39:695-698.
5. Tang Y, Schmitt-Ott K, Qian K, Kagiyama S, Phillips MI. Vigilant vectors: adeno-associated virus with a biosensor to switch on amplified therapeutic genes in specific tissues in life-threatening diseases. Methods. 2002;28:259-266.
6. Michael LH, Ballantyne CM, Zachariah JP, Gould KE, Pocius JS, Taffet GE, Hartley CJ, Pham TT, Daniel SL, Funk E, Entman ML. Myocardial infarction and remodeling in mice: effect of reperfusion. Am J Physiol. 1999;277:H660-H668.
7. Michael LH, Entman ML, Hartley CJ, Youker KA, Zhu J, Hall SR, Hawkins HK, Berens K, Ballantyne CM. Myocardial ischemia and reperfusion: a murine model. Am J Physiol. 1995;269:H2147-H2154.
8. Foresti R, Goatly H, Green CJ, Motterlini R. Role of heme oxygenase-1 in hypoxia-reoxygenation: requirement of substrate heme to promote cardioprotection. Am J Physiol Heart Circ Physiol. 2001;281: H1976-H1984.
9. Abraham NG, Lavrovsky Y, Schwartzman ML, Stoltz RA, Levere RD, Gerritsen ME, Shibahara S, Kappas A. Transfection of the human heme oxygenase gene into rabbit coronary microvessel endothelial cells: protective effect against heme and hemoglobin toxicity. Proc Natl Acad Sci USA. 1995;92:6798-6802.
10. Motterlini R, Foresti R, Bassi R, Green CJ. Curcumin, an antioxidant and anti-inflammatory agent, induces heme oxygenase-1 and protects endothelial cells against oxidative stress. Free Radic Biol Med. 2000;28:1303-1312.
11. Motterlini R, Foresti R, Intaglietta M, Winslow RM. NO-mediated activation of heme oxygenase: endogenous cytoprotection against oxidative stress to endothelium. Am J Physiol. 1996;270:H107-H114.
12. Otterbein LE, Choi AM. Heme oxygenase: colors of defense against cellular stress. Am J Physiol Lung Cell Mol Physiol. 2000;279: L1029-L1037.
13. Yachie A, Niida Y, Wada T, Igarashi N, Kaneda H, Toma T, Ohta K, Kasahara Y, Koizumi S. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest. 1999;103:129-135.
14. Jayakumar J, Suzuki K, Sammut IA, Smolenski RT, Khan M, Latif N, Abunasra H, Murtuza B, Amrani M, Yacoub MH. Heat shock protein 70 gene transfection protects mitochondrial and ventricular function against ischemia-reperfusion injury. Circulation. 2001;104:1303-1307.
15. Okubo S, Wildner O, Shah MR, Chelliah JC, Hess ML, Kukreja RC. Gene transfer of heat-shock protein 70 reduces infarct size in vivo after ischemia/reperfusion in the rabbit heart. Circulation. 2001;103:877-881.
16. Maillard L, Peycher P, Fichaux O, Vincentelli-Djeffal D. [Gene therapy with VEGF]. Presse Med. 2000;29:1731-1737.
17. Morse MA. Technology evaluation: VEGF165 gene therapy, Valentis Inc. Curr Opin Mol Ther. 2001;3:97-101.
18. Schwarz ER, Speakman MT, Patterson M, Hale SS, Isner JM, Kedes LH, Kloner RA. Evaluation of the effects of intramyocardial injection of DNA expressing vascular endothelial growth factor (VEGF) in a myocardial infarction model in the rat-angiogenesis and angioma formation. J Am Coll Cardiol. 2000;35:1323-1330.
19. Vulapalli SR, Chen Z, Chua BH, Wang T, Liang CS. Cardioselective overexpression of HO-1 prevents 1/R-induced cardiac dysfunction dysfunction and apoptosis. Am J Physiol Heart Circ Physiol. 2002;283:H688-H694.
20. Chatterjee S, Stewart AS, Bish LT, Jayasankar V, Kim EM, Pirolli T, Burdick J, Woo YJ, Gardner TJ, Sweeney HL. Viral gene transfer of the antiapoptotic factor Bcl-2 protects against chronic postischemic heart failure. Circulation. 2002;106:I212-I217.
21. Tung TC, Cui G, Oshima K, Laks H, Sen L. Balanced expression of mitochondrial apoptosis regulatory proteins correlates with long-term survival of cardiac allografts. Am J Physiol Heart Circ Physiol. 2003;285:H2832-H2841.
22. Phillips MI, Mohuczy-Dominiak D, Coffey M, Galli SM, Kimura B, Wu P, Zelles T. Prolonged reduction of high blood pressure with an in vivo, nonpathogenic, adeno-associated viral vector delivery of AT1-R mRNA antisense. Hypertension. 1997;29:374-380.